Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trans-mucosal Diclofenac Potassium for Pain in Irreversible Pulpitis
NCT04585438Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Sep 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of diclofenac in irreversible pulpitis, postoperative pain, sponsored by Cairo University. Status: unknown.
02
Drugs
diclofenac
03
Conditions
irreversible pulpitispostoperative pain
Beyond the preview
Go deeper on NCT04585438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04585438.